[go: up one dir, main page]

BR9911344A - Composto, undecanoato de ment, uso do mesmo, formulação farmacêutica, e, kit para a contracepção masculina. - Google Patents

Composto, undecanoato de ment, uso do mesmo, formulação farmacêutica, e, kit para a contracepção masculina.

Info

Publication number
BR9911344A
BR9911344A BR9911344-9A BR9911344A BR9911344A BR 9911344 A BR9911344 A BR 9911344A BR 9911344 A BR9911344 A BR 9911344A BR 9911344 A BR9911344 A BR 9911344A
Authority
BR
Brazil
Prior art keywords
compound
kit
pharmaceutical formulation
male contraception
ment undecanoate
Prior art date
Application number
BR9911344-9A
Other languages
English (en)
Inventor
Dirk Leysend
Hendrikus Adrianus Anton Voort
Original Assignee
Akzo Nobel Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nobel Nv filed Critical Akzo Nobel Nv
Publication of BR9911344A publication Critical patent/BR9911344A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0051—Estrane derivatives
    • C07J1/0066—Estrane derivatives substituted in position 17 beta not substituted in position 17 alfa
    • C07J1/007—Estrane derivatives substituted in position 17 beta not substituted in position 17 alfa the substituent being an OH group free esterified or etherified
    • C07J1/0074—Esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/16—Masculine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/26—Androgens

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cultivation Receptacles Or Flower-Pots, Or Pots For Seedlings (AREA)
  • Percussion Or Vibration Massage (AREA)
  • Medicinal Preparation (AREA)

Abstract

"COMPOSTO, UNDECANOATO DE MENT, USO DO MESMO, FORMULAçãO FARMACêUTICA, E, KIT PARA A CONTRACEPçãO MASCULINA" A invenção refere-se ao novo andrógeno (7<244>, 7 <225>) -7-metil-17[(1-oxoundecil)oxi]estr-4-en-3-ona ( undecanoato de MENT). Este composto se distingue favoravelmente de outros derivados de testosterona pelo fato de que ele possui uma boa solubilidade em meios oleosos. Ele exibe particularmente uma boa potência dissolvida em relação à testosterona. O composto é particularmente adequado para a administração por meio de injeção.
BR9911344-9A 1998-06-19 1999-06-14 Composto, undecanoato de ment, uso do mesmo, formulação farmacêutica, e, kit para a contracepção masculina. BR9911344A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP98202052 1998-06-19
PCT/EP1999/004102 WO1999067271A1 (en) 1998-06-19 1999-06-14 Testosterone derivative

Publications (1)

Publication Number Publication Date
BR9911344A true BR9911344A (pt) 2001-03-13

Family

ID=8233831

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9911344-9A BR9911344A (pt) 1998-06-19 1999-06-14 Composto, undecanoato de ment, uso do mesmo, formulação farmacêutica, e, kit para a contracepção masculina.

Country Status (26)

Country Link
US (3) US6437158B1 (pt)
EP (1) EP1087986B1 (pt)
JP (1) JP2002518514A (pt)
KR (1) KR100596649B1 (pt)
CN (1) CN1172949C (pt)
AT (1) ATE215961T1 (pt)
AU (1) AU756739B2 (pt)
BR (1) BR9911344A (pt)
CA (1) CA2333985C (pt)
CZ (1) CZ293319B6 (pt)
DE (1) DE69901250T2 (pt)
DK (1) DK1087986T3 (pt)
ES (1) ES2175989T3 (pt)
HK (1) HK1034263A1 (pt)
HU (1) HUP0102274A3 (pt)
ID (1) ID27260A (pt)
IL (1) IL139689A (pt)
NO (1) NO316518B1 (pt)
NZ (1) NZ508299A (pt)
PL (1) PL191285B1 (pt)
PT (1) PT1087986E (pt)
RU (1) RU2216546C2 (pt)
SK (1) SK282796B6 (pt)
TR (1) TR200003743T2 (pt)
WO (1) WO1999067271A1 (pt)
ZA (1) ZA200006813B (pt)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6756366B1 (en) * 1999-04-06 2004-06-29 Akzo Nobel N.V. Orally active androgens
AU8201601A (en) * 2000-07-28 2002-02-13 Akzo Nobel Nv 16alpha-methyl or ethyl substituted estrogens
JP3774888B2 (ja) * 2001-11-28 2006-05-17 日本化薬株式会社 ステロイド類化合物のｌｃ−ｍｓによる高感度検出法
TW200403065A (en) 2002-05-30 2004-03-01 Akzo Nobel Nv New etonogestrel esters
TW200404552A (en) * 2002-05-30 2004-04-01 Akzo Nobel Nv Self administered contraception
TW200400041A (en) * 2002-05-30 2004-01-01 Akzo Nobel Nv Use of new etonogestrel esters
GB0304927D0 (en) 2003-03-04 2003-04-09 Resolution Chemicals Ltd Process for the production of tibolone
JO2505B1 (en) 2003-03-14 2009-10-05 باير شيرنغ فارما اكتنجيسيلشافت Pharmacy methods and formulations for obtaining acceptable serum testosterone levels
JO2492B1 (en) 2003-04-28 2009-10-05 شيرينج ايه جي A pharmaceutical formula in the form of aqueous gel for the skin use of its active ingredients
PE20050677A1 (es) 2003-12-22 2005-10-04 Akzo Nobel Nv Esteroides con perfil androgenico y progestagenico mixto
UA89964C2 (ru) 2004-09-08 2010-03-25 Н.В. Органон 15β-ЗАМЕЩЕННЫЕ СТЕРОИДЫ, КОТОРЫЕ ИМЕЮТ СЕЛЕКТИВНУЮ ЭСТРОГЕННУЮ АКТИВНОСТЬ
EP1879382B1 (en) 2006-07-10 2017-09-06 Samsung Electronics Co., Ltd. Multi-screen display apparatus and method for digital broadcast receiver
WO2008101030A1 (en) * 2007-02-13 2008-08-21 The Regents Of The University Of California Methods for amplifying steroid hormone effects
US20090017107A1 (en) * 2007-07-13 2009-01-15 Oral Delivery Technology Ltd. Novel composition to increase libido
US20090018107A1 (en) * 2007-07-13 2009-01-15 Oral Delivery Technology Ltd. Novel composition to increase muscle strength
US20100303937A1 (en) * 2009-06-01 2010-12-02 Michael Farber Novel composition to increase testosterone levels
CN102558267A (zh) * 2012-01-13 2012-07-11 宜城市共同药业有限公司 庚酸睾酮的制备方法
EP2833944A4 (en) 2012-04-06 2016-05-25 Antares Pharma Inc ADMINISTRATION OF TESTOSTERONE COMPOSITIONS BY NEEDLE-SUPPORTED NOZZLE INJECTION
HUE066268T2 (hu) 2013-02-11 2024-07-28 Antares Pharma Inc Csökkentett kioldóerõt igénylõ tûs befecskendezõ eszköz

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5342834A (en) * 1989-04-07 1994-08-30 The Population Council, Inc. Method for androgen supplementation

Also Published As

Publication number Publication date
ATE215961T1 (de) 2002-04-15
EP1087986A1 (en) 2001-04-04
CZ293319B6 (cs) 2004-04-14
CA2333985A1 (en) 1999-12-29
CZ20004779A3 (en) 2001-06-13
ZA200006813B (en) 2002-02-21
DK1087986T3 (da) 2002-06-17
US20040033999A1 (en) 2004-02-19
US6437158B1 (en) 2002-08-20
AU756739B2 (en) 2003-01-23
HUP0102274A3 (en) 2002-08-28
NO20006455L (no) 2000-12-18
IL139689A (en) 2004-09-27
EP1087986B1 (en) 2002-04-10
ID27260A (id) 2001-03-22
PT1087986E (pt) 2002-08-30
CA2333985C (en) 2007-04-10
TR200003743T2 (tr) 2001-07-23
KR100596649B1 (ko) 2006-07-06
DE69901250D1 (de) 2002-05-16
NO316518B1 (no) 2004-02-02
KR20010052850A (ko) 2001-06-25
SK282796B6 (sk) 2002-12-03
CN1172949C (zh) 2004-10-27
HUP0102274A2 (hu) 2001-12-28
RU2216546C2 (ru) 2003-11-20
ES2175989T3 (es) 2002-11-16
WO1999067271A1 (en) 1999-12-29
HK1034263A1 (en) 2001-10-19
PL191285B1 (pl) 2006-04-28
PL344987A1 (en) 2001-11-19
DE69901250T2 (de) 2002-10-17
NO20006455D0 (no) 2000-12-18
JP2002518514A (ja) 2002-06-25
SK19402000A3 (sk) 2001-07-10
AU4610199A (en) 2000-01-10
CN1305488A (zh) 2001-07-25
NZ508299A (en) 2003-04-29
US6989378B2 (en) 2006-01-24
US20050153949A1 (en) 2005-07-14
IL139689A0 (en) 2002-02-10

Similar Documents

Publication Publication Date Title
BR9911344A (pt) Composto, undecanoato de ment, uso do mesmo, formulação farmacêutica, e, kit para a contracepção masculina.
BR0107445A (pt) Formulação farmacêutica, uso de fulvestrante na preparação de uma formulação farmacêutica, e, seringa ou frasco
BRPI0111639B8 (pt) uso de uma molécula de ácido oligodeoxinucléico imunoestimulatório e composição farmacêutica.
EP2348032A3 (en) 6.Alpha.,9.alpha.-difluoro-17.alpha.-&#39;(2-furanylcarboxyl) oxy]-11.beta.-hydroxy-16.alpha.-methyl-3-oxo-androst-1,4,-diene-17-carbothiotic acid s-fluoromethyl ester as an anti-inflammatory agent
MX9301032A (es) Compuestos farmaceuticos y procedimento para su preparacion
ITMI921601A1 (it) Uso di nor- e omo-derivati di acidi biliari come promotori di assorbimento di farmaci.
KR950700894A (ko) 탁솔 유도체(Taxol derivatives)
CO5040216A1 (es) Agonistas de adenosina a 1, proceso para su preparacion y composiciones farmaceuticas que los contienen
NO800447L (no) Derivater av difenylhydantoin, farmasoeytiske preparater inneholdende slike preparater, samt fremgangsmaate til fremstilling av de aktive forbindelser
ZA881030B (en) 19-nor steroids substituted in position 7,their preparation,application as medicaments,compositions containing them
IL100621A0 (en) Tetrazole derivatives,their preparation and pharmaceutical compositions containing them
MY128392A (en) 6ALPHA, 9ALPHA-DIFLUORO-17ALPHA-(2-FURANYLCARBOXYL)OXY]-11ß-HYDROXY-16ALPHA-METHYL-3-OXO-ANDROST-1,4,-DIENE-17-CARBOTHIOIC ACID S-FLUOROMETHYL ESTER AS AN ANTI-INFLAMMATORY AGENT
DK1051177T3 (da) Steroide 3-O-Sulfamatderivater som inhibitorer af östronsulfatase
NO943187D0 (no) Indolderivater som steroid 5-alfa-reduktasehemmere
NZ505614A (en) Pentasaccharides and pharmaceutical compositions thereof, useful as anti blood clotting agnets
KR890006639A (ko) 벤조티아진 디옥사이드 유도체
UY26144A1 (es) Nuevas formas cristalinas de un antibiótico macrolido.
BR0013769A (pt) Esteróides estrogênicos não aromáticos, composição farmacêutica, e, uso de um composto esteróide
PA8475701A1 (es) Derivados de 3(2-oxo-[1,3&#39;]bipirrolidinil-3-ilidenmetil)-cephems
AR018888A1 (es) Un derivado de testosterona, uso del mismo, una formulacion farmaceutica que comprende a dicho derivado y un kit para la anticoncepcion masculina
AR034194A1 (es) Un compuesto esteroide, su uso, una composicion farmaceutica que lo comprende y un kit para la anticoncepcion masculina
AR008474A1 (es) Derivado de 9-dihidroeritromicina a 6,9; 11,12-diciclocarbonato, composicion farmaceutica y preparacion bactericida que lo contienen y su uso
KR950000704A (ko) 로라카베프 하이드로클로라이드 c_1-c_3 알콜 용매화물 및 그의 용도
AR036462A1 (es) Un compuesto esteroidal y su uso para la fabricacion de un medicamento
KR960700361A (ko) 5-아미노아세틸아미노술폰아닐리드 화합물

Legal Events

Date Code Title Description
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: INDEFIRO O PEDIDO DE ACORDO COM O(S) ARTIGO(S) 8O E 13 DA LPI.

B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: MANTIDO O INDEFERIMENTO UMA VEZ QUE NAO FOI APRESENTADO RECURSO DENTRO DO PRAZO LEGAL.